You are Here : Moneycontrol Forum Forum Topics Stocks

Godavari Drugs

Godavari Drugs
BSE 35.35 0.86%
NSE NT*

Sector : Pharmaceuticals

Godavari Drugs
Add to
Opinions 2603
4393
Followers

Can I buy Godavari Drugs, Should I buy Godavari Drugs, Do I buy Godavari Drugs?

  • BSE

    35.35 0.86%

  • NSE

    NT*

5 Day

Nov 20

BSE

33.55 -2.33 %

Volume 8098

Nov 23

BSE

34.95 4.17 %

Volume 6330

Nov 24

BSE

34.75 -0.57 %

Volume 1655

Nov 25

BSE

34.25 -1.44 %

Volume 4109

Nov 26

BSE

35.05 2.34 %

Volume 2270

Your Strategy BUYSELLHOLD

Nov 27, 16:00

We take the quality of the messages posted on forum as seriously as our articles. Kindly follow our Code of Conduct and refrain from posting any abusive, promotional or gibberish content on forum.
Disclaimer : The views expressed in the forum are the views of the user writing the post, and not that of moneycontrol.com. You agree, by accessing this forum, that moneycontrol.com bears no liability for any posts on this forum or, any losses suffered by following any advice posted on this forum. moneycontrol.com operates this real time, open, unmoderated, private forum for users to exchange information and to discuss various investing techniques. moneycontrol.com or, its personnel do not post anything, or vet the content posted, on this forum. moneycontrol.com reserves the right to deny service to anyone. You, and not moneycontrol.com, assume the entire cost and risk of any trading you choose to undertake. You are solely responsible for making your own investment decisions. If you choose to engage in such transactions with or without seeking advice from a licensed and qualified financial advisor or entity, then such decision and any consequences flowing therefrom are your sole responsibility.
Buy
What makes you think Havells India is a Buy?

Price

  • BSE

    35.35 0.86%

  • NSE

    NT*

Share Target

Ok

Get your own permanent - nickname

Choose your nickname

Your permanent Nickname can be distinct from your username and no one need know the link between the two.

Sections